3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide

C16H19N3O2 — CID 167758778

IUPAC3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide
SMILESCc1cc(NC(=O)CCc2ccc3c(c2)CCCO3)n[nH]1
InChIInChI=1S/C16H19N3O2/c1-11-9-15(19-18-11)17-16(20)7-5-12-4-6-14-13(10-12)3-2-8-21-14/h4,6,9-10H,2-3,5,7-8H2,1H3,(H2,17,18,19,20)
InChIKeyQHHSWZPLMJJNCA-UHFFFAOYSA-N
MW285.35 g/mol
LogP2.61
Rot. Bonds4

About 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide

3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide (PubChem CID 167758778) has the molecular formula C16H19N3O2 and a molecular weight of 285.35 g/mol. Its IUPAC name is 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide.

Molecular Properties

Compound Name3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide
PubChem CID167758778
Molecular FormulaC16H19N3O2
Molecular Weight285.35 g/mol
Exact Mass285.15
IUPAC Name3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide
SMILESCc1cc(NC(=O)CCc2ccc3c(c2)CCCO3)n[nH]1
InChIInChI=1S/C16H19N3O2/c1-11-9-15(19-18-11)17-16(20)7-5-12-4-6-14-13(10-12)3-2-8-21-14/h4,6,9-10H,2-3,5,7-8H2,1H3,(H2,17,18,19,20)
InChIKeyQHHSWZPLMJJNCA-UHFFFAOYSA-N
XLogP2.61
TPSA67.01 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500285.35
LogP ≤ 52.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(4-ethylphenyl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide
CID 47215997
3-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(6-methyl-2-pyridinyl)propanamide
CID 17455509
3-(3,4-dihydro-2H-chromen-6-yl)-N-methylpropanehydrazide
CID 116844990
4-(3,4-dihydro-2H-chromen-6-yl)-N'-methylbutanehydrazide
CID 116846526
N-[2-(3,4-dihydro-2H-chromen-6-yl)ethyl]butanamide
CID 110790414
N-(4-acetylphenyl)-3-(2,3-dihydro-1-benzofuran-5-yl)propanamide
CID 53352123
5-(3,4-dihydro-2H-chromen-6-yl)-N'-methylpentanehydrazide
CID 116846644
N-(3,4-dihydro-2H-chromen-6-ylmethyl)-3-(3,4-dimethoxyphenyl)propanamide
CID 91831785
3-(2,3-dihydro-1,4-benzodioxin-6-yl)-N-(4-methyl-2-pyridinyl)propanamide
CID 9453893
3-(2,3-dihydro-1-benzofuran-5-yl)-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
CID 71754922
3-(1,3-benzodioxol-5-yl)-N-(4,5-dimethyl-1H-pyrazol-3-yl)propanamide
CID 115594806
N-(2,4-dichlorophenyl)-3-(2,3-dihydro-1-benzofuran-5-yl)propanamide
CID 5055071

Frequently Asked Questions

What is the IUPAC name of 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide?
The IUPAC name of 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide (CID 167758778) is 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide.
What is the SMILES notation for 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide?
The canonical SMILES for 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide is Cc1cc(NC(=O)CCc2ccc3c(c2)CCCO3)n[nH]1.
What is the InChIKey of 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide?
The InChIKey is QHHSWZPLMJJNCA-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19N3O2/c1-11-9-15(19-18-11)17-16(20)7-5-12-4-6-14-13(10-12)3-2-8-21-14/h4,6,9-10H,2-3,5,7-8H2,1H3,(H2,17,18,19,20).
What are the key properties of 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide?
3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide has a molecular weight of 285.35 g/mol, XLogP of 2.61, 4 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(3,4-dihydro-2H-chromen-6-yl)-N-(5-methyl-1H-pyrazol-3-yl)propanamide is sourced from PubChem (CID 167758778), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).